These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6146820)

  • 1. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
    Sawada T; Hirayama M; Nakata T; Takeda T; Takasugi N; Mori T; Maeda K; Koide R; Hanawa Y; Tsunoda A
    Lancet; 1984 Aug; 2(8397):271-3. PubMed ID: 6146820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T; Kidowaki T; Sakamoto I; Hashida T; Matsumura T; Nakagawa M; Kusunoki T
    Cancer; 1984 Jun; 53(12):2731-5. PubMed ID: 6722733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
    Suita S
    J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging evaluation of infants with neuroblastoma detected by VMA screening spot test.
    Fujioka M; Saiki N; Aihara T; Yamamoto K
    Pediatr Radiol; 1988; 18(6):479-83. PubMed ID: 3054769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
    Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
    Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
    Hayashi Y; Ohi R; Yaoita S; Nakamura M; Kikuchi Y; Konno T; Tsuchiya S; Shiraishi H
    J Pediatr Surg; 1995 Mar; 30(3):467-70. PubMed ID: 7760244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan.
    Kodama K; Nakata T; Ishii J; Mitani K; Tsunooka H; Masaoka A; Aoyama M
    Am J Public Health; 1985 Feb; 75(2):173-5. PubMed ID: 3966625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of neuroblastoma in infancy in Japan.
    Sawada T; Kidowaki T; Sugimoto T; Kusunoki T
    Med Pediatr Oncol; 1984; 12(2):101-3. PubMed ID: 6700544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass screening of neuroblastoma in infancy.
    Sawada T; Todo S; Fujita K; Iino S; Imashuku S; Kusunoki T
    Am J Dis Child; 1982 Aug; 136(8):710-2. PubMed ID: 6808827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
    Takeda T; Shimada M; Iizuka S; Takasugi N
    Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J
    J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
    Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of neuroblastoma in patients identified by mass screening using urinary catecholamine metabolites.
    Tanabe M; Yoshida H; Ohnuma N; Iwai J; Takahashi H
    J Pediatr Surg; 1993 Apr; 28(4):617-21. PubMed ID: 8483079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects.
    Sawada T; Sugimoto T; Tanaka T; Kawakatsu H; Ishii T; Matsumura T; Horii Y
    Med Pediatr Oncol; 1987; 15(1):14-7. PubMed ID: 3561327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of mass screening for neuroblastoma in infancy.
    Sawada T; Matsumura T; Kawakatsu H; Sugimoto T; Kuroda H; Hosoi H; Michihata T; Saida T; Hino T
    Am J Pediatr Hematol Oncol; 1991; 13(1):3-7. PubMed ID: 2029075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral adrenal neuroblastoma.
    Ishiguro Y; Iio K; Seo T; Nagaya M; Ito T
    Eur J Pediatr Surg; 1994 Feb; 4(1):37-9. PubMed ID: 8199131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.